Overview

ELAZOP Switching Study in Korea

Status:
Completed

Trial end date:
2011-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the safety and efficacy of switching to ELAZOP from prior pharmacotherapy in patients with open-angled glaucoma.

Phase:

Phase 4

Details

Lead Sponsor:

Alcon Research